{"id":"https://openalex.org/W1978472391","doi":"https://doi.org/10.1016/j.breast.2010.02.001","title":"Adjuvant trastuzumab in routine clinical practice and the impact of cardiac monitoring guidelines on treatment delivery","display_name":"Adjuvant trastuzumab in routine clinical practice and the impact of cardiac monitoring guidelines on treatment delivery","publication_year":2010,"publication_date":"2010-03-12","ids":{"openalex":"https://openalex.org/W1978472391","doi":"https://doi.org/10.1016/j.breast.2010.02.001","mag":"1978472391","pmid":"https://pubmed.ncbi.nlm.nih.gov/20226661"},"language":"en","primary_location":{"id":"doi:10.1016/j.breast.2010.02.001","doi":"https://doi.org/10.1016/j.breast.2010.02.001","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.breast.2010.02.001","pdf_url":"http://www.thebreastonline.com/article/S0960977610000391/pdf","source":{"id":"https://openalex.org/S181123643","display_name":"The Breast","issn_l":"0960-9776","issn":["0960-9776","1532-3080"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Breast","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.thebreastonline.com/article/S0960977610000391/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089818936","display_name":"Louise Janet Murray","orcid":"https://orcid.org/0000-0003-0658-6455","observed_orcids":["https://orcid.org/0000-0003-0658-6455"]},"institutions":[{"id":"https://openalex.org/I2802720485","display_name":"Weston Park Cancer Centre","ror":"https://ror.org/042gs1a72","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802720485","https://openalex.org/I4210102902"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"L.J. Murray","raw_affiliation_strings":["Department of Clinical Oncology, Weston Park Hospital, Sheffield, UK. Louise.Murray@sth.nhs.uk","Dept. of Clinical Oncology, Weston Park Hospital, Sheffield, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, Weston Park Hospital, Sheffield, UK. Louise.Murray@sth.nhs.uk","institution_ids":["https://openalex.org/I2802720485"]},{"raw_affiliation_string":"Dept. of Clinical Oncology, Weston Park Hospital, Sheffield, UK","institution_ids":["https://openalex.org/I2802720485"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041674098","display_name":"Sundareswaran Ramakrishnan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802720485","display_name":"Weston Park Cancer Centre","ror":"https://ror.org/042gs1a72","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802720485","https://openalex.org/I4210102902"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S. Ramakrishnan","raw_affiliation_strings":["Dept of Clinical Oncology, Weston Park Hospital, Sheffield, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Clinical Oncology, Weston Park Hospital, Sheffield, UK","institution_ids":["https://openalex.org/I2802720485"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112100648","display_name":"Laurence O\u2019Toole","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801732343","display_name":"Royal Hallamshire Hospital","ror":"https://ror.org/00514rc81","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801732343","https://openalex.org/I4210102902"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"L. O'Toole","raw_affiliation_strings":["Dept of Cardiology, Royal Hallamshire Hospital, Sheffield, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Cardiology, Royal Hallamshire Hospital, Sheffield, UK","institution_ids":["https://openalex.org/I2801732343"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089231091","display_name":"I.H. Manifold","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802720485","display_name":"Weston Park Cancer Centre","ror":"https://ror.org/042gs1a72","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802720485","https://openalex.org/I4210102902"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"I.H. Manifold","raw_affiliation_strings":["Dept of Clinical Oncology, Weston Park Hospital, Sheffield, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Clinical Oncology, Weston Park Hospital, Sheffield, UK","institution_ids":["https://openalex.org/I2802720485"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111986454","display_name":"O. Prakash Purohit","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802720485","display_name":"Weston Park Cancer Centre","ror":"https://ror.org/042gs1a72","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802720485","https://openalex.org/I4210102902"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"O.P. Purohit","raw_affiliation_strings":["Dept of Clinical Oncology, Weston Park Hospital, Sheffield, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Clinical Oncology, Weston Park Hospital, Sheffield, UK","institution_ids":["https://openalex.org/I2802720485"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051980635","display_name":"Robert Edward Coleman","orcid":"https://orcid.org/0000-0002-4275-1043","observed_orcids":["https://orcid.org/0000-0002-4275-1043"]},"institutions":[{"id":"https://openalex.org/I91136226","display_name":"University of Sheffield","ror":"https://ror.org/05krs5044","country_code":"GB","type":"education","lineage":["https://openalex.org/I91136226"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"R.E. Coleman","raw_affiliation_strings":["Academic Unit of Clinical Oncology, University of Sheffield, Sheffield, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Unit of Clinical Oncology, University of Sheffield, Sheffield, UK","institution_ids":["https://openalex.org/I91136226"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5089818936"],"corresponding_institution_ids":["https://openalex.org/I2802720485"],"apc_list":{"value":3200,"currency":"USD","value_usd":3200},"apc_paid":{"value":3200,"currency":"USD","value_usd":3200},"fwci":1.2483,"has_fulltext":true,"cited_by_count":16,"citation_normalized_percentile":{"value":0.81461592,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"19","issue":"5","first_page":"339","last_page":"344"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.9023000001907349,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.9023000001907349,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.05009999871253967,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.010300000198185444,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9700000286102295},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.9589999914169312},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.7570000290870667},{"id":"https://openalex.org/keywords/left-ventricular-ejection-fraction","display_name":"left ventricular ejection fraction","score":0.9639999866485596},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.6700000166893005},{"id":"https://openalex.org/keywords/cardiology-referral","display_name":"cardiologist referral","score":0.8069999814033508},{"id":"https://openalex.org/keywords/treatment-completion","display_name":"treatment completion","score":0.5070000290870667},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9169999957084656},{"id":"https://openalex.org/keywords/routine-clinical-practice","display_name":"routine clinical practice","score":0.6309999823570251}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9821388721466064},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.865476131439209},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.6845793724060059},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.5937737226486206},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.44689470529556274},{"id":"https://openalex.org/C2777982462","wikidata":"https://www.wikidata.org/wiki/Q2481887","display_name":"Adjuvant therapy","level":3,"score":0.41047748923301697},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3832889199256897},{"id":"https://openalex.org/C19527891","wikidata":"https://www.wikidata.org/wiki/Q1120908","display_name":"Medical physics","level":1,"score":0.3529573976993561},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33294808864593506},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.1609371304512024},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.15250852704048157},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.0840480625629425}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006321","descriptor_name":"Heart","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013318","descriptor_name":"Stroke Volume","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016277","descriptor_name":"Ventricular Function, Left","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017024","descriptor_name":"Chemotherapy, Adjuvant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017410","descriptor_name":"Practice Guidelines as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018709","descriptor_name":"Statistics, Nonparametric","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.breast.2010.02.001","doi":"https://doi.org/10.1016/j.breast.2010.02.001","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.breast.2010.02.001","pdf_url":"http://www.thebreastonline.com/article/S0960977610000391/pdf","source":{"id":"https://openalex.org/S181123643","display_name":"The Breast","issn_l":"0960-9776","issn":["0960-9776","1532-3080"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Breast","raw_type":"journal-article"},{"id":"pmid:20226661","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20226661","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast (Edinburgh, Scotland)","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.breast.2010.02.001","doi":"https://doi.org/10.1016/j.breast.2010.02.001","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.breast.2010.02.001","pdf_url":"http://www.thebreastonline.com/article/S0960977610000391/pdf","source":{"id":"https://openalex.org/S181123643","display_name":"The Breast","issn_l":"0960-9776","issn":["0960-9776","1532-3080"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Breast","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1978472391.pdf","grobid_xml":"https://content.openalex.org/works/W1978472391.grobid-xml"},"referenced_works_count":28,"referenced_works":["https://openalex.org/W1964641698","https://openalex.org/W1978621531","https://openalex.org/W1998245427","https://openalex.org/W2016183255","https://openalex.org/W2042878804","https://openalex.org/W2045324973","https://openalex.org/W2082096722","https://openalex.org/W2101099004","https://openalex.org/W2101253730","https://openalex.org/W2103648677","https://openalex.org/W2109775164","https://openalex.org/W2122472092","https://openalex.org/W2123803615","https://openalex.org/W2126262886","https://openalex.org/W2131058213","https://openalex.org/W2140074016","https://openalex.org/W2141469083","https://openalex.org/W2146384083","https://openalex.org/W2149445224","https://openalex.org/W2149908785","https://openalex.org/W2152647863","https://openalex.org/W2167507724","https://openalex.org/W2233806202","https://openalex.org/W2469805673","https://openalex.org/W2509575626","https://openalex.org/W2585382523","https://openalex.org/W4234771565","https://openalex.org/W4245244523"],"related_works":["https://openalex.org/W1696275957","https://openalex.org/W2398890145","https://openalex.org/W2889933012","https://openalex.org/W237703817","https://openalex.org/W4285725954","https://openalex.org/W2765800912","https://openalex.org/W2307330081","https://openalex.org/W192444809","https://openalex.org/W2589513644","https://openalex.org/W2923201831"],"abstract_inverted_index":{"Trastuzumab":[0],"delivery":[1],"and":[2,100,118],"changes":[3],"in":[4,10,16,88],"left":[5],"ventricular":[6],"ejection":[7],"fraction":[8],"(LVEF)":[9],"110":[11],"patients":[12,35,93,135],"receiving":[13,116],"adjuvant":[14],"trastuzumab":[15,38,54,70,109,124,138],"routine":[17],"practice":[18],"are":[19],"investigated.":[20],"The":[21,129],"potential":[22],"impact":[23],"of":[24,56,62,80,84,92,145],"new,":[25],"less":[26],"stringent":[27],"UK":[28],"cardiac":[29],"monitoring":[30],"guidelines":[31,131],"is":[32,86],"examined.":[33],"86":[34],"(78%)":[36],"completed":[37,43],"on":[39,110,139],"schedule.":[40],"11":[41],"(10%)":[42],"treatment":[44],"despite":[45],"delay(s)":[46],"to":[47,104,114,136],"allow":[48,133],"LVEF":[49,58,81],"recovery,":[50,59],"7":[51],"(6%)":[52],"discontinued":[53,69],"because":[55],"insufficient":[57],"2":[60],"(2%)":[61],"whom":[63],"developed":[64],"symptomatic":[65],"cardiotoxicity.":[66],"6":[67],"(5%)":[68],"for":[71],"non-cardiac":[72],"reasons.":[73],"With":[74],"the":[75,78,90],"newer":[76],"guidelines,":[77],"value":[79],"lower":[82],"limit":[83],"normal":[85],"important":[87],"determining":[89],"proportion":[91],"who":[94],"require":[95,142],"angiotensin-converting":[96],"enzyme":[97],"inhibitors":[98],"(ACEIs)":[99],"cardiology":[101,121],"referral:":[102],"up":[103,113],"100%":[105],"could":[106],"potentially":[107,132],"complete":[108,137],"schedule":[111,140],"with":[112],"60%":[115],"ACEIs":[117],"25%":[119],"requiring":[120],"referral.":[122],"Adjuvant":[123],"was":[125],"well":[126],"tolerated":[127],"overall.":[128],"new":[130],"more":[134],"but":[141],"higher":[143],"levels":[144],"cardiological":[146],"intervention.":[147]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}